Status:
NOT_YET_RECRUITING
pCAD-POAF 3 Year Follow-up
Lead Sponsor:
China National Center for Cardiovascular Diseases
Conditions:
Coronary Artery Disease
Atrial Fibrillation
Eligibility:
All Genders
18-85 years
Brief Summary
This study will include the subjects who enrolled in pCAD-POAF trial (NCT05009914) to observe clinical outcomes 3 years after surgery. The primary outcome is the AF burden during 3-day continuous ECG...
Detailed Description
This study aimed to observe clinical outcomes 3 years after surgery in patients enrolled in pCAD-POAF trial. After completing the pCAD-POAF trial, investigators would not make any other interventions...
Eligibility Criteria
Inclusion
- This study will include the subjects who enrolled in pCAD-POAF trial
Exclusion
- This study will include the subjects who enrolled in pCAD-POAF trial
Key Trial Info
Start Date :
August 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
430 Patients enrolled
Trial Details
Trial ID
NCT07146061
Start Date
August 1 2025
End Date
January 1 2027
Last Update
August 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai Hospital, CAMS & PUMC
Beijing, China